Ciprofloxacin Otic
Product Images NDC 42195-550

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin Otic (NDC 42195-550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xspire Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (D0125acf 1879 452d Ba29 C0f753653789 01)

FDA Label Image

Figure (D0125acf 1879 452d Ba29 C0f753653789 02)

FDA Label Image

Figure (D0125acf 1879 452d Ba29 C0f753653789 03)

FDA Label Image

Figure (D0125acf 1879 452d Ba29 C0f753653789 04)

FDA Label Image

Image Of 5 mg Package Label (D0125acf 1879 452d Ba29 C0f753653789 05)

Image Of 5 mg Package Label (D0125acf 1879 452d Ba29 C0f753653789 05)
This is a description of a sterile and preservative-free otic solution of 0.2% ciprofloxacin. The solution comes in 14 single-use containers, each containing 0.25mL. The containers should be discarded after use and the unused ones should be stored in a protective pouch to avoid light exposure. The solution is meant for otic use only and must be stored at a temperature between 15° and 25°C (59° to 77°F). The manufacturer of the solution is The Ritedose Corporation with distribution by Xspire. However, the address of distribution is not readable due to errors.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.